ESHO Congratulates Best Abstract Competition Winner Makka Adam Ali on Her Newly Published Study on Classical Hodgkin Lymphoma
ESHO/LinkedIn

ESHO Congratulates Best Abstract Competition Winner Makka Adam Ali on Her Newly Published Study on Classical Hodgkin Lymphoma

Ethiopian Society of Hematology and Oncology – ESHO shared on LinkedIn:

“ESHO Research Spotlight | New Publication

The Ethiopian Society of Hematology and Oncology (ESHO) congratulates Makka Adam Ali, 2nd Place winner in the Best Abstract Competition at ESHO’s 6th Annual Meeting (Addis Ababa, June 2026), on her newly published study!

About the Research:

Titled ‘Prognostic Impact of FoxP3 and PD1 Expression in the Tumor Microenvironment (TME) of Classical Hodgkin Lymphoma (cHL),’ the paper evaluates survival outcomes in Ethiopian cHL patients—highlighting the prognostic value of disease risk, lymphocyte count, and FoxP3/PD-1 immune biomarkers in advancing local cancer care.

Congratulations to Makka and all contributors for strengthening locally generated oncology evidence!

Learn more about ESHO.”

Title: Prognostic Impact of FoxP3 and PD1 Expression in the Tumor Microenvironment (TME) of Classical Hodgkin Lymphoma (cHL)

Authors: Makka Adam, Rawleigh Howe, Menal Hassen, Selfu Girma, Sofia Yimam, Senedu Bekele, Tsegaye Hailu, Amha Gebremedhin, Yonas Bekuretsion, Amanuel Damie, Senait Ashenafi, Anna Kwiecinska, Mats Jerkeman

Read the Full Article on Cancers

You can also read: Hodgkin Lymphoma in 2026: What the New EHA Guidelines Recommend

ESHO Congratulates Best Abstract Competition Winner Makka Adam Ali on Her Newly Published Study on Classical Hodgkin Lymphoma